Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ischemic Stroke
Pharma
Bayer nabs 1st-in-class FDA nod for stroke med asundexian
The FDA has signed off on Bayer’s factor XIa inhibitor asundexian, ushering in one of the first major revolutions in stroke prevention in decades.
Fraiser Kansteiner
Nov 9, 2026 9:10pm
NIH stops Xarelto arm of stroke trial due to safety, efficacy
Feb 10, 2026 4:04pm
AstraZeneca's Brilinta wins FDA nod for stroke patients
Nov 6, 2020 11:18am
AZ's Brilinta aims for label boost with stroke priority review
Jul 16, 2020 11:21am
AstraZeneca's Brilinta tops aspirin in reducing stroke risks
Jan 27, 2020 10:42am
Otsuka aims to battle generics with "smart" pill container
Sep 13, 2016 3:28pm
